We recently compiled a list of the 10 Best High-Yield Dividend Stocks To Invest In. In this article, we are going to take a ...

In a report released today, Charles Rhyee from TD Cowen maintained a Buy rating on CVS Health (CVS – Research Report), with a price target of ...

CVS faces significant 2025 headwinds, including intense pharmacy competition, threatened new federal government pressures, ...

CVS Health Corp (CVS) stock saw a modest uptick, ending the day at $52.62 which represents a slight increase of $0.66 or 1.27% from the prior close of $51.96. The stock opened at $52.23 and touched a ...

The lawsuit claims that three major healthcare companies were pushing up the price of insulin by 1,200 percent.

CVS Health shares are trading lower by 2.7% during Thursday's session. Shares of insurers and pharmacy benefit manager stocks ...

CVS Health ( CVS 4.35%) is a stock that's been struggling badly for multiple years and is coming off a brutal performance in ...

Shares of CVS Health Corp. CVS advanced 1.11% to $52.14 Wednesday, on what proved to be an all-around favorable trading ...

CVS Health® (NYSE: CVS) will hold a conference call with analysts and investors on Wednesday, February 12th, 2025, at 8:00 a.m. ET to discuss fourth quarter and full year 2024 financial results.

CVS Health Corp. closed 34.84% short of its 52-week high of $80.75, which the company achieved on March 28th.

Analysts reveal how these healthcare giants are primed for massive gains with 2026's game-changing Medicare Advantage boost ...

PSA: Getting intentional about your well-being doesn’t have to be groundbreaking or bank-breaking. Instead, you can boost ...